Search results
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 27 minutes agoThe [Inaudible] category are mRNA vaccines, which are the centerpiece of our oncology strategy. Our mRNA cancer vaccines are designed to target multiple...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 12 hours agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 7 hours agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
WSAU Wausau· 2 weeks agoBy Blake Brittain (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 8 hours agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 3 hours agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 8 hours agoIn pre-market activity on the Nasdaq, BioNTech shares were trading at $88.05, down 5.04 percent. The year-over-year change was mainly due to lower commercial revenues from ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 weeks agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 5 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 weeks agovaccine was the third jab to be approved for use in the UK in January 2021 after the Pfizer/BioNTech...
